Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems.
Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 6
Abstract
The present study has been undertaken to investigate the possible link between calcitonin gene related peptide (CGRP) and opioid receptor transduction systems in the neuroprotective mechanism of pharmacological preconditioning. Occlusion of the bilateral carotid artery for 17 min, followed by reperfusion for 24 h, was employed to produce ischemia and reperfusion (I/R) induced cerebral injury in mice. Cerebral infarct size was measured by using triphenyltetrazolium chloride staining. Memory was assessed using the Morris water maze (MWM) test. Degree of motor incoordination was evaluated using the inclined beam walk test, rota-rod test, and lateral push test. Morphine (8 mg/kg, ip), an opioid agonist, and capsaicin (0.1 mg/kg, iv), a CGRP releasing agent, were administered 24 h before surgery to separate groups of animals to induce pharmacological preconditioning. Bilateral carotid artery occlusion, followed by reperfusion, produced a significant increase in the cerebral infarct size and impaired memory as well as motor coordination. Morphine and capsaicin treatment produced both a significant decrease in the cerebral infarct size and a reversal of I/R-induced impairment of memory and motor-coordination. Morphine-induced (8 mg/kg, ip) neuroprotective effects were completely decreased by sumatriptan (8 mg/kg, ip, a CGRPrelease inhibitor) administered 1 h before and 6 h and 12 h after morphine administration. Capsaicin-induced neuroprotection was decreased by naloxone (5 mg/kg, ip, an opioid antagonist) administered 1 h before and 6 h and 12 h after capsaicin administration. These findings indicate that the transduction systems mediating morphine- and capsaicin-induced pharmacological preconditioning in brain are possibly interlinked with one another.
Authors and Affiliations
Ashish Rehni, Thakur Singh, Amteshwar Jaggi, Nirmal Sing
Keywords
Related Articles
- EP ID EP160099
- DOI -
- Views 111
- Downloads 0
Treatment of dyslipidemia in patients with diabetes mellitus.
The article reviews the key aspects of pathophysiology of diabetic dyslipidemia, its treatment and associated risk of cardiovascular complications. It examines the difference in lipidmetabolism between type 1 and type 2...
Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients.
KYNA, an antagonist of ionotropic glutamate receptors and alpha7 nicotinic receptors, has been found as well in the brain as in the periphery. The altered metabolism of KYNA, especially its deficiency, can lead to the en...
Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methyl-piperazin-1-yl)propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione.
Two series of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methylpiperazin-1-yl)-propyl]-3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione derivatives were synthesized and tested for anticonvulsant activity in the maximum e...
Genetic factors underlying differential blood platelet sensitivity to inhibitors.
Blood platelets are not only the primary defence mechanism involved in physiological hemostasis, but also their disorders constitute a crucial risk factor in arterial thrombosis. As arterial thrombi are composed of predo...
Interleukin-13-induced activation of signal transducer and activator of transcription 6 is mediated by an activation of Janus kinase 1 in cultured human bronchial smooth muscle cells.
Background: The current study was carried out to identify the JAK molecule(s) that is involved in the IL-13-induced activation of STAT6 in cultured human bronchial smooth muscle cells (hBSMCs). Methods: Cultured hBSMCs w...